Skip to main content
. 2021 Mar 17;113(10):1369–1378. doi: 10.1093/jnci/djab034

Figure 1.

Figure 1.

Analysis compares Functional Assessment of Cancer Therapy–Ovary Trial Outcome Index (FACT-O-TOI) between short-term survivors (STS) and long-term survivors (LTS) at each assessment interval using mixed hierarchical regression, adjusting for age, stage, grade, performance status, residual disease, treatment, and baseline FACT-O-TOI for cycle 4 and later. Solid line represents FACT-O-TOI in LTS from mixed model; dotted line represents FACT-O-TOI in STS from mixed model. This analysis shows statistically significant differences between survivor groups at baseline that continue to grow over time. Error bars represent ±1 standard error. Rx = treatment.